BioSpectrum Asia, October 2026. From symptom control to disease modification: can precision biology, new modalities and blood-brain barrier technologies turn neurology's breakthroughs into a ...

With support from the government of Ontario, Piramal Pharma is investing $5,314,000 to upgrade site infrastructure at their ...

Japan’s Chugai Pharmaceutical and InxMed (Hong Kong) have entered into a worldwide license agreement regarding SPYK04, a ...

Telix recently completed enrollment in the Phase 3 BiPASS study of its proprietary 68Ga-PSMA-PET agents, Illuccix® and Gozellix® for pre-biopsy prostate cancer diagnosis. The ompany has positively ...

The Faculty of Computer and Mathematical Sciences (FCMS) of The Hong Kong Polytechnic University (PolyU) and the Institute of ...

Researchers from the National University of Singapore (NUS) have developed a next-generation electronic skin that can both ...

Singapore’s PRECISE has been designated GA4GH’s first Regional Hub Institution for Asia Pacific and has signed agreements ...

Viome Life Sciences has signed a Memorandum of Understanding (MoU) with Druk Holding & Investments Ltd (DHI), the investment arm of the Royal Government of Bhutan, and Gelephu Mindfulness City (GMC), ...

Grünenthal, a global leader in pain management and research, and DKSH Business Unit Healthcare, a strategic healthcare business partner and leading provider of Market Expansion Services for ...

Deep Origin’s PREDICTS consortium has deployed AI-based ADMET safety models across four drug discovery organisations, with wet-lab results feeding back into the system to improve future predictions.

United Immunity, a clinical stage biotechnology company, has raised a total of ¥2.2 billion in private financing, comprising ...

A new Digestive Health Centre has opened at the Woodlands Hospital in Singapore. The Centre brings together comprehensive ...